GenieUs Genomics Announces Completion of Phase 2 Clinical Trial Enrollment
GenieUs Genomics (GenieUs), in collaboration with trial sites at Duke University School of Medicine and the Lewis Katz School of Medicine at Temple University, today announces the completion of enrollment of 50 patients in the Phase 2 clinical trial, ROAR-DiGAP, focused on precision health and patient stratification in amyotrophic lateral sclerosis (ALS).